CL2019001309A1 - Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment. (divisional application n ° 01238-2016) - Google Patents

Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment. (divisional application n ° 01238-2016)

Info

Publication number
CL2019001309A1
CL2019001309A1 CL2019001309A CL2019001309A CL2019001309A1 CL 2019001309 A1 CL2019001309 A1 CL 2019001309A1 CL 2019001309 A CL2019001309 A CL 2019001309A CL 2019001309 A CL2019001309 A CL 2019001309A CL 2019001309 A1 CL2019001309 A1 CL 2019001309A1
Authority
CL
Chile
Prior art keywords
fragment
fusion
putative partial
protein
putative
Prior art date
Application number
CL2019001309A
Other languages
Spanish (es)
Inventor
Nicole Tischler
Pinto Gonzalo Andrés Barriga
Original Assignee
Fund Ciencia Para La Vida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fund Ciencia Para La Vida filed Critical Fund Ciencia Para La Vida
Priority to CL2019001309A priority Critical patent/CL2019001309A1/en
Publication of CL2019001309A1 publication Critical patent/CL2019001309A1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Fragmento de la proteína Gc de fusión del género Hantavirus, el cual consiste de la secuencia de del dominio III parcial putativo de Gc, o de la región troncal parcial putativa de Gc; donde dicho fragmento inhibe la fusión de dicho virus con una célula eucarionte. Composición farmacéutica, que comprende a dicho fragmento y procedimiento de preparación de dicho fragmento de la proteína Gc de fusión del género Hantavirus.Fragment of the fusion Gc protein of the genus Hantavirus, which consists of the sequence of the putative partial domain III of Gc, or the putative partial trunk region of Gc; wherein said fragment inhibits the fusion of said virus with a eukaryotic cell. Pharmaceutical composition, comprising said fragment and method of preparing said fragment of the fusion Gc protein of the genus Hantavirus.

CL2019001309A 2019-05-14 2019-05-14 Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment. (divisional application n ° 01238-2016) CL2019001309A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2019001309A CL2019001309A1 (en) 2019-05-14 2019-05-14 Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment. (divisional application n ° 01238-2016)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2019001309A CL2019001309A1 (en) 2019-05-14 2019-05-14 Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment. (divisional application n ° 01238-2016)

Publications (1)

Publication Number Publication Date
CL2019001309A1 true CL2019001309A1 (en) 2019-07-05

Family

ID=67440491

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019001309A CL2019001309A1 (en) 2019-05-14 2019-05-14 Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment. (divisional application n ° 01238-2016)

Country Status (1)

Country Link
CL (1) CL2019001309A1 (en)

Similar Documents

Publication Publication Date Title
CO2020016559A2 (en) Antibodies that target hiv gp120 and methods of use
CO2019002556A2 (en) Pharmaceutical composition
MX2020013169A (en) Camptothecin conjugates.
CL2017001920A1 (en) Human antibodies against Ebola virus glycoprotein
ECSP18096095A (en) ALPHA-SINUCLEIN ANTIBODIES AND USES OF THEM
UY36304A (en) FUSION PROTEINS, RECOMBINANT BACTERIA AND METHODS OF USE OF THE RECOMBINANT BACTERIA
BR112019000693A2 (en) mucocharge compositions and methods for use
AR108468A1 (en) CD40L-Fc FUSION POLIPEPTIDES AND THE SAME USE METHODS
CL2016002794A1 (en) Peptide vaccine comprising a mutant ras peptide and a chemotherapeutic agent
BR112017016897A2 (en) fungal strains and methods of use
PH12020551716A1 (en) Anti-ror antibody constructs
CO2020013833A2 (en) Anti-programmed death antibody-ligand 1 and its use
UY37977A (en) NEW COMBINATIONS OF DEFLOLIANTS
CO2021010786A2 (en) Inactivated apxia, apxiia, and apxiiia toxins
DOP2024000040A (en) HBV VACCINES AND HBV TREATMENT METHODS
MX2020004561A (en) Bispecific antibodies binding alk-1 and bmpr-2.
CL2020000734A1 (en) Expansion and use of enlarged nk cell fractions.
DOP2017000246A (en) POLIPEPTIDES DIRECTED TO HIV FUSION
CO2020007601A2 (en) Modified brucella vaccine strain for the treatment of brucellosis
CU20210008A7 (en) SOLUBILIZED ASPIRASES
CO2019011300A2 (en) Composition of infliximab containing the histidine buffer system
BR112018072699A2 (en) certain protein kinase inhibitors
CL2020002294A1 (en) Use of an anti-p-selectin antibody
CL2021000107A1 (en) Methods of treating hfpef using dapagliflozin and compositions comprising the same
CL2019001310A1 (en) Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment. (divisional application n ° 01238-2016)